Document ID: chunk:federal_register_of_legislation:F2024L01153:body:0:p13
Version: federal_register_of_legislation:F2024L01153
Segment Type: other
Provision Reference: 
Character Range: 34347–37749

name for each substance specified in the table for that substance; and

               (d)  may use the acronym specified in the table for the following substances in addition to the name required for those substances by paragraph (c):

              (i) docosahexaenoic acid; and
                   (ii)  eicosapentaenoic acid; and
  (iii)  arachidonic acid.
                      Example The statement may use 'Docosahexaenoic acid (DHA)' or 'Docosahexaenoic acid', but not 'DHA'.

            (7) If the statement includes information expressed in accordance with subsection 2.9.1—24(7), that information must be in an additional column at the right hand side of the column shown in the table.

            (8) Information included in the additional column required by subsection (7) must be in the form required by this section.

               Note  For an example nutrition information statement including information expressed in accordance with subsection 2.9.1—24(7), see section S29—10A.

           2.9.1—26 How average quantity is to be calculated

             Despite section 1.1.1—6, the method in paragraph 1.1.1—6(3)(c) must not be used to calculate the *average quantity of a substance in infant formula or follow‑on formula.

           2.9.1—27 Requirements for use of stage numbers

            (1) The following numbers may be used on the label on a package of infant formula or follow-on formula to identify for consumers that the product is infant formula or follow‑on formula:

               (a) if the product is infant formula—the number '1'; and
               (b) if the product is follow-on formula—the number '2'.

            (2) A number used in accordance with subsection (1) must appear:

               (a) on the front of the package of the product; and
               (b) immediately adjacent to:
                   (i) for infant formula—the statement required by paragraph   2.9.1—21(2)(a); and
                   (ii) for follow-on formula—the statement required by paragraph                2.9.1—21(2)(b).

            (3) Subsection (2) does not prevent a number used in accordance with subsection (1) from also appearing elsewhere on the label.

           2.9.1—28 Prohibited representations

            (1) The label on a package of infant formula or follow-on formula must not contain:

               (a) a picture of an infant; or
               (b) a picture that idealises the use of infant formula or follow-on formula; or
               (c) information relating to:
                   (i) for infant formula—follow-on formula, a special medical purpose product for infants, a formulated supplementary food or a formulated supplementary food for young children; or
                   (ii) for follow-on formula—infant formula, a special medical purpose product for infants,a formulated supplementary food or a formulated supplementary food for young children.
               (d) the word 'humanised' or 'maternalised' or any word or words having the same or similar effect; or
               (e) the words 'human milk oligosaccharide', 'human identical milk oligosaccharide' or any word or words having the same or similar effect; or
               (f) the abbreviations 'HMO' or HiMO' or any abbreviation having the same or similar effect; or
               (g) words claiming that the formula is suitable for all infants; or
               (h)